
==== Front
Cancer Med
Cancer Med
10.1002/(ISSN)2045-7634
CAM4
Cancer Medicine
2045-7634
John Wiley and Sons Inc. Hoboken

10.1002/cam4.7392
CAM47392
CAM4-2023-07-3368.R3
Research Article
Research Articles
Fully automated viability and toxicity screeningâ€”A reliable allâ€inâ€one attempt
Liedtke etÂ al.
Liedtke Victoria https://orcid.org/0000-0001-7838-5818
1
Weiss Romano 1
Skifov Anastasia 1
RÃ¶diger Stefan 1 2
Schenk Lysann 1 lysann.schenk@b-tu.de

1 Faculty of Natural Sciences Brandenburg University of Technology Cottbusâ€Senftenberg Senftenberg Germany
2 Faculty of Health Sciences Brandenburg University of Technology Cottbusâ€Senftenberg Senftenberg Germany
* Correspondence
Lysann Schenk, Faculty of Natural Sciences, Brandenburg University of Technology Cottbusâ€Senftenberg, UniversitÃ¤tsplatz 1, Senftenberg 01968 Germany.
Email: lysann.schenk@b-tu.de

22 6 2024
6 2024
13 12 10.1002/cam4.v13.12 e739223 1 2024
12 7 2023
26 1 2024
Â© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editing. However, these assays are often timeâ€consuming, expensive, and reproducibility is an issue. To overcome this, we developed a fast and cheap assay that combines a fully automated multispectral fluorescence microscopy platform with a nuclei staining and openâ€source software analysis.

Methods

Here, we generated different LEDGF/p75 model cell lines to validate the effect on proliferation and chemosensitivity. Therefore, a fast protocol for an optimized allâ€inâ€one attempt for cytotoxicity screenings and proliferation analysis of adherent cells in a 96â€well plate format was established using differential staining with two fluorescent dyes (Hoechst 33342 and propidium iodide) for live/dead cell discrimination. Subsequently, an automated cell nuclei count and analysis were performed using bioimage informatics.

Results

With the new established assay technology, up to 50,000 cells/well can be detected and analyzed in a 96â€well plate, resulting in a fast and accurate verification of viability and proliferation with consistency of 98% compared to manual counting. Our screening revealed that LEDGF depletion using CRISPR/Cas9 showed a diminished proliferation and chemosensitivity independent of cell line origin. Moreover, LEDGF depletion caused a significant increase in ğ›¾H2AX foci, indicating a substantial increase in DNA double strand breaks. LEDGF/p75 overexpression enhanced proliferation and chemoresistance underlining the role of LEDGF in DNA damage response.

Conclusion

Independent of cancer cell type, LEDGF/p75 is a central player in DNA damage repair and is implicated in chemoresistance. Moreover, our automated fluorescence biosensor technology allowed fast and reliable data acquisition without any fixation or additional washing steps. Additionally, data analysis was implemented using the modular openâ€source software that can be adapted as needed.

In this manuscript, we provide a fast, easy and costâ€efficient allâ€inâ€one attempt for analyzing proliferation and cytotoxicity in a wide range of human cancer cell lines. Additionally, it is a reliable, nontoxic, and metabolismâ€independent method for comparing genetically modified cell lines or different chemotherapeutic drugs.

automated system
bioimage informatics
CRISPR/Cas9
cytotoxicity
viability
Friedrich Naumann Stiftung 10.13039/501100007443 Bundesministerium fÃ¼r Bildung und Forschung 10.13039/501100002347 03WKDB2C source-schema-version-number2.0
cover-dateJune 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.4 mode:remove_FC converted:22.06.2024
Liedtke V , Weiss R , Skifov A , RÃ¶diger S , Schenk L . Fully automated viability and toxicity screeningâ€”A reliable allâ€inâ€one attempt. Cancer Med. 2024;13 :e7392. doi:10.1002/cam4.7392

Victoria Liedtke and Romano Weiss contributed equally to this work and shared first authorship.

Stefan RÃ¶diger and Lysann Schenk shared senior authorship.
==== Body
pmc1 INTRODUCTION

Genomic alterations can cause cancer, and with the genome editing tool CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats / CRISPR associated enzyme 9), a technology has been developed to explore genetic changes in a fast and easy way. 1 , 2 The identification of potential drivers for cancer, as well as potential therapy targets, has been already accelerated through the introduction of RNA interference (RNAi) but CRISPR/Cas9 technology is speeding up the research advances even further. In comparison to other genome editing tools such as transcription activatorâ€like effector nuclease (TALEN) or zinc finger nucleases, CRISPR/Cas9 is efficient, easy programmable, modifies chromosomal targets with high fidelity. It offers the possibility of multiplex genome editing as well as transcriptional regulation. 3 Moreover, CRISPR/Cas9 technology allows not only the knockout (KO) of genes and gene modulation but also directed knockin of gene expression cassettes into a safe harbor locus. 4

A major obstacle in cancer treatment is chemoresistance. The list of involved genes is long and can also vary depending on the type of cancer. The transcriptional coâ€activator lens epithelium derived growth factor, LEDGF (also known as dense fine speckled autoantigen of 70â€‰kDa, DFS70), is a multiâ€functional chromatinâ€binding protein and its longer splice variant LEDGF/p75 is known to be overexpressed in different types of cancer, for example, breast and prostate cancer cells. 5 , 6 Moreover, it is crucial for an efficient DNA damage response repair pathway and is involved in chemoresistance. 7 , 8 , 9 During stress conditions, LEDGF/p75 binds to stressâ€response elements (STREs) to activate the expression of stressâ€related genes, resulting in increased chemoresistance. 6

A robust drug sensitivity assay is a prerequisite to establish a reliable drug efficacy and potency. Typically, proliferation and cytotoxicity for example, sensitivity towards chemotherapeutics are assessed by colorimetric assays measuring the cell content or metabolic activity. Sulforhodamine B (SRB) stains the cellular protein content and is, since 1990, a widely used and costâ€efficient assay. 10 , 11 The binding of the dye is stoichiometric, and its intensity is proportional to the cell mass. Furthermore, the MTT (3â€(4,5â€dimethylthiazolâ€2â€yl)â€2,5â€diphenyltetrazolium bromide) assay, which measures mitochondrial NADH dehydrogenase activity, and the ATP assay (which uses, e.g., luciferin to evaluate ATP level), are frequently used metabolic assays. Nevertheless, the reproducibility is often challenging due to many fixing, staining, and washing steps that might cause cell detachment or incomplete excess dye removal. Moreover, most of these assays are timeâ€consuming. The aforementioned problems that arise by the usage of colorimetric assays can be overcome by the deployment of automatic analysis of image data. In addition, manual assessment of data is prone to error due to the subjectivity of the assessor.

Here we propose a strategy that combines fluorescence staining with bioimage informatics to access cell viability and cytotoxicity in an automated, highâ€throughput manner. Using bioimage informatics, extensive image datasets can be analyzed fast and reproducibly. 8 , 12 In previous studies, we have described the foundations of a measurement platform which has been used to obtain images for autoimmune diagnostics, 13 , 14 DNA damage analysis 12 , 15 and biomedical applications 16 using different biosensor approaches. 17 , 18 , 19

Additionally, CRISPR/Cas9 technology can be used to modulate the expression of oncogenes and its impact on the chemosensitivity. In a previous study, we established already LEDGFâ€modified HEpâ€2 cell lines which showed an increased chemoresistance with LEDGF/p75 overexpression (LEDGF/p75 OE) and a reversed effect in LEDGF KO cells. 8 To provide further evidence regarding the changes in chemosensitivity we designed an assay setup to analyze the effect of LEDGF KO and LEDGF/p75 OE in different cell lines.

2 MATERIALS AND METHODS

2.1 Antibodies

The following antibodies were used in this study: antiâ€ğ›¾H2AX (Cell Signaling Technology Cat# 2577, RRID:AB_2118010, Massachusetts, USA), antiâ€Câ€LEDGF/p75 (Bethylâ€Laboratories, Cat# A300â€848A, RRID:AB_2171223, Texas, USA), antiâ€Î±â€actinin (Santa Cruz Biotechnology Cat# scâ€17829, RRID:AB_626633, Massachusetts, USA), antiâ€Î²â€tubulin (Cell Signaling Technology, Cat# 2128, RRID:AB_823664, Massachusetts, USA), antiâ€mouseâ€IgGÎº BPâ€HRP (Santa Cruz Biotechnology, Cat# scâ€516102, RRID:AB_2687626, Texas, USA), antiâ€rabbit HRP (Sigma Aldrich, Cat# AP132P, RRID:AB_90264, Missouri, USA) and Î±â€Mouseâ€IgGâ€Alexa Fluor 488 (Abcam Cat# ab150113, RRID:AB_2576208, Cambridge, UK).

2.2 Cell lines and culture

Human epithelial type 2 (HEpâ€2, (ATCC Cat# CCLâ€23, RRID:CVCL_1906), passage number 9â€“18), human bone osteosarcoma epithelial cells (U2OS, (ATCC Cat# HTBâ€96, RRID:CVCL_0042), passage number 5â€“19) and human colon cell line (LoVo, (ATCC Cat# CCLâ€229, RRID:CVCL_0399), passage number 5â€“16) wildâ€type (WT) cells as well as LEDGF KO and EGFPâ€LEDGF/p75 overexpressing (OE) cells were grown up to 80% confluence in DMEM/Ham's F12 supplemented with 10% FBS (Biowest, NuaillÃ©, France), 2â€‰mMâ€‰lâ€glutamine (Merck Millipore, Massachusetts, USA) and penicillin/streptomycin (Merck Millipore, Massachusetts, USA) in a humidified incubator at 37Â°C and 5% CO2.

2.3 Cloning

For the generation of LEDGF KO cells, singleâ€guide (sg) RNA for CRISPR/Cas9â€mediated genome editing sgRNA_DF70_E1 (AGATGAAAGGTTATCCCCAT, targeting exon 1 of PSIP1 gene) was cloned into the mammalian expression vector pSpCas9 (BB)â€2Aâ€GFP (PX458; Addgene plasmid # 48138 kindly provided by Feng Zhang, Ph.D. 20 ). For the expression of EGFPâ€LEDGF/p75 a sgRNA targeting the human safe harbor locus (AAVS1, sgRNA_AAVS1: CCAATCCTGTCCCTAG) was cloned into a pSpCas9 (BB)â€2Aâ€GFPâ€plasmid (PX458; Addgene plasmid # 48138), and a gBlock HDR fragment (containing attB sites for Gateway cloning and an EGFPâ€LEDGF/p75 coding sequence) into pAAVS1â€Pâ€CAGâ€DESTâ€plasmid (Addgene plasmid #â€‰80490, kindly provided by Knut Woltjen, Ph.D. 4 ).

2.4 Generation of LEDGFâ€modified cell clones

CRISPR/Cas9â€modified HEpâ€2, U2OS, and LoVo cells were generated according to the method described by Liedtke etÂ al. 8 Briefly, cells were seeded in sixâ€well plates (Th. Geyer, Renningen, Germany), incubated for 24â€‰h and subsequently transfected with px458_sgR_DFS70_E1 using Lipofectamineâ„¢ 3000 according to manufacturer's instructions (Thermo Fisher Scientific, Massachusetts, USA). For the EGFPâ€LEDGF/p75 expression, LEDGF KO cells were coâ€transfected with px458_sgRNA_AAVS1 and pAAVS1_CAGâ€EGFPâ€LEDGF/p75. Transfected cells were enriched by EGFP selection via FACS using S3e cell sorter (Bioâ€Rad). Fluorescent, single cell colonies were picked after 7â€“10â€‰days to establish LEDGF/p75 reâ€expressing cell lines. Obtained cell clones were analyzed to verify the integration of the expression cassette at the AAVS1 locus by PCR as described in Ocegueraâ€Yanez etÂ al. 4 showing only heterozygous integrations. The expression level of LEDGF/p75 was verified by western blot analysis due to relatively quantification of protein bands by ImageJ. 21

2.5 Proliferation analysis

Cells were seeded at 5â€‰Ã—â€‰103 cells/well into multiple 96â€well plates (Th.Geyer, Renningen, Germany) and incubated for 24â€“96â€‰h at 37Â°C and 5% CO2. To determine the accuracy of cell seeding, one plate was used as a 0â€‰h control. For proliferation analysis after 0â€“96â€‰h, the corresponding plates were stained as explained in SectionÂ 2.7 and analyzed as explained in SectionÂ 2.8.

2.6 Chemotherapeutic treatment

Cells were seeded at 5â€‰Ã—â€‰103 cells/well into 96â€well plates (Th. Geyer, Renningen, Germany) and incubated for 24â€‰h. Subsequently, cells were exposed to 5â€‰Î¼M of etoposide (ETP) (as indicated in the figures and the procedure (Supplement 1â€”DataÂ S1)).

2.7 Staining with DNA incorporating dyes

After treatment for the indicated time (FiguresÂ 3 and 4), cells were stained with Hoechst 33342 (4â€‰Î¼g/mL, Merck Millipore, Massachusetts, USA) and PI (2â€‰Î¼g/mL AppliChem, Darmstadt, Germany) in 1Ã—PBS (Biowest, NuaillÃ©, France) for 15â€‰min at 37Â°C, 5% CO2 and images were taken by the automated VideoScan imaging platform 13 , 22 with UPlan S Apo objective 10Ã—/ 0.16âˆ/âˆ’/FN 26.5 (Olympus, Hamburg, Germany) using an Olympus IX fluorescence microscope (Olympus, Hamburg, Germany).

2.8 Digital image analysis and bioimage informatics

Analysis of proliferation and cytotoxicity assays after Hoechst/PI staining was performed using the fully automated multispectral fluorescence microscopy VideoScan platform 13 , 22 In principle, and for users who do not possess the VideoScan system, our allâ€inâ€one attempt is compatible with common fluorescence microscopes. PI/Hoechstâ€stained cells were measured using an exposure time of 0.5â€“1â€‰s. Each well of the 96â€well plate was dissected into 12 subunits, imaged in meandering sequence at 10Ã— magnification and reassembled as a single image. Images were subsequently analyzed using bioimage informatics as follows. All image processing steps were performed using the library scikitâ€image v.0.17.2. The obtained images were converted to grayscale and all parts of the image outside the analyzed well were masked using the image average to not interfere with detection. Additionally, the image was slightly smoothed before detection using median filtering (4â€‰Ã—â€‰4 neighborhood; skimage.filters.median) to reduce the noise. Cell count per image was determined via Laplacian of Gaussian Blob detection as implemented in scikitâ€image skimage.feature.blob_log; v.0.17.2; following settings: min_sigma: 1.5, max_sigma: 4, num_sigma: 10, threshold: 0.005, overlap: 0.35, exclude_borders: False. To exclude dead cells, the PIâ€positive cells were subtracted from the number of Hoechstâ€positive cells. Prominent problems during image acquisition and data analysis were addressed in a table in (Supplement 1 and 2â€”DataÂ S1).

2.9 Sulforhodamine B assay

To determine cell proliferation, cells were seeded at a density of 5â€‰Ã—â€‰103 cells/well in a 96â€well plate (Th. Geyer, Renningen, Germany) and a SRB assay was performed according to nature protocols. 11 Briefly, 96â€well plates were fixed with 10% ice cold TCA solution for 1â€‰h at 4Â°C, followed by washing 4Ã— with slowâ€running tap water. Plates were allowed to air dry and 0.057% SRB solution was added directly into the wells and incubated a RT for 30â€‰min. Plates were rinsed again 4Ã— with tap water containing 1% acetic acid and allowed to air dry at room temperature. Trisâ€base solution (10â€‰mM, pHâ€‰10.5) was added directly into the wells and incubated on a shaker for 5â€‰min to solubilize the proteinâ€bound SRBâ€dye. Measuring was performed by OD analysis at 510â€‰nm.

2.10 Immunofluorescence

Cells were seeded at 5â€‰Ã—â€‰103 cells/well on 10â€well slides (Hecht Assistant, Sondheim v. d. RhÃ¶n, Germany) and incubated for 24â€‰h. For analysis, cells were fixed with 4% formaldehyde for 15â€‰min at RT and permeabilized with 0.3% Triton Xâ€100 (AppliChem, Darmstadt, Germany) while blocking with 5% BSA/PBS. Primary antibody was added and incubated at RT for 1â€‰h. Slides were washed with 1Ã—PBS, then incubated with secondary antibody and DAPI (5â€‰Î¼g/mL) for 1â€‰h in the dark at RT. Fluorophore photostability was increased by coating slides with mounting medium (RotiÂ®â€Mount FluorCare, Carl Roth GmbH, Karlsruhe, Germany). Analysis was performed using a confocal laser scanning microscope LSM 800 (Zeiss, Oberkochen, Germany), 60Ã— magnification with oil immersion (microscope settings are listed in Supplement 3â€”DataÂ S1). Foci formation (100â€“250 nuclei/image) was analyzed using NucDetect software, excluding mitotic cells (NucDetect 0.15.0, written in Python 3.9, available at https://pypi.org/project/NucDetect/).

2.11 Immunoblotting

Cells (1â€‰Ã—â€‰106) were harvested and resuspended in 50â€‰Î¼L 2Ã— LÃ¤mmliâ€buffer and protein content was determined using Pierceâ„¢ BCA Protein Assay Kit (Thermo Fisher Scientific, Massachusetts, USA). Immunoblotting was performed using standard protocols. 23 Antiâ€Câ€LEDGF was diluted in 2% milk powder (Carl Roth, Karlsruhe, Germany) in TBS/0.1% Tweenâ€20 while antiâ€Î±â€actinin and antiâ€Î²â€tubulin antibodies were diluted in 5% BSA (Carl Roth, Karlsruhe, Germany) in TBS/0.1% Tweenâ€20 (AppliChem, Darmstadt, Germany). HRPâ€conjugated secondary antibodies were diluted in 5% milk powder in TBS/0.1% Tweenâ€20. Nonâ€saturated and backgroundâ€subtracted band intensities were quantified using ImageJ software. 22 LEDGF protein levels were normalized to loading control. Prior antiâ€Î±â€actinin incubation, PVDF membrane was stripped with stripping buffer (2% SDS, 500â€‰mM Tris/HCl (pHâ€‰6.8), 0.8% Î²â€mercaptoethanol) for 30â€‰min at 50Â°C.

2.12 Statistical analysis

All data were statistically analyzed with the statistical computing language Râ€‰â‰¥â€‰4.2.1. 24 The Kolmogorovâ€“Smirnov test was used for testing normal distribution. To control the Î± error inflation, the Bonferroni correction is applied or Tukey's HSD test (stats::TukeyHSD()) is used to test the differences between the mean values of the sample for significance. Thereby, the stats::TukeyHSD() function uses the Tukeyâ€“Kramer procedure 25 pâ€‰<â€‰0.05â€ were considered as significant. Experiments were conducted with at least three biological replicates. Data were further analyzed using RKWard v. 0.7.5 26 for the R statistical computing environment using the packages visreg v. 2.7.0 27 and report v. 0.3.5. A linear model was estimated using ordinary least squares (OLS). The foci count data were processed using the countfitteR 28 package to determine the distributions and mean values. Data were further analyzed using RKWard v. 0.7.1zâ€‰+â€‰0.7.2â€‰+â€‰devel2 13 for the R statistical computing environment. Doseâ€“response curves were fitted (95% confidence interval) with multiparametric functions (EXD3: Threeâ€parameter exponential decay model; LL4: Fourâ€parameter logâ€logistic model) from the drc package. 29 The optimal model was selected by using the Akaike information criterion (AIC) as criterion.

3 RESULTS

3.1 Software enables reliable quantitative cell counting with lifeâ€death discrimination for cytotoxicity screenings

So far, we have used the SRB assay for proliferation and chemosensitivity analysis, but this assay is timeâ€consuming and requires several washing steps. Moreover, a fixation step is needed, which can cause dislodging of adherent cells. To achieve a good reproducibility, a higher number of replicates was often necessary. Therefore, a fast fluorescenceâ€based approach using Hoechst/PI staining of nonâ€fixed, living cells in combination with an automated microscopy platform was established (FigureÂ 1).

FIGURE 1 Workflow for automated fluorescentâ€based proliferation and cytotoxicity screening. (A) After counting, cells are seeded at appropriate cell densities into 96â€well plates. (B) Compound of interest is added directly to the cells without washing. Include compound solvent and medium only control. Check possible autofluorescence of the compounds ahead of the experiment! (C) After treatment, Hoechst/PIâ€solution is directly added to the cells in the well. If background fluorescence is detectable, a washing step with 1x PBS is required. (D) Pictures of each well are taken by a fully automated imaging platform (e.g., VideoScan), followed by digital image analysis (by e.g., VideoScan analyzer). Determination of growth and, if applicable, ED50 is determined by data analysis and statistical analysis.

The Hoechst/PI staining allows a cell count (rather than protein content or metabolic activity) as well as live/dead discrimination. As representative shown in FigureÂ 2 for HEpâ€2 cells, cells should be evenly distributed (FigureÂ 2A), and stained properly with Hoechst and PI to allow single cell detection (FigureÂ 2A,B) even after 96â€‰h. We applied a Python script 30 for automatic cell counting. The enlarged image sections show the precision of the software, which was tested on U2OS, HEpâ€2, and LoVo cells. Detection limits can be considered below 500 and above 50,000 cells per 96 well, depending on cell morphology, due to insufficient focus points or clumpy cell formation.

FIGURE 2 Detection of stained nuclei by digital image analysis software and comparison of cells counted manually and by digital image analysis software. (A) HEpâ€2 cells stained with Hoechst and counterstained with PI directly after seeding (0â€‰h) and (B) after 96â€‰h of growth. Images were taken by a fully automated microscopy platform, nuclei are visible as light gray spots and can be overlayed. Digital image analysis software uses Laplacianâ€ofâ€Gaussian Blob detection, as implemented by the skimage library. Each detected nucleus is marked with a red circle. To determine cell viability, cells stained with PI are subtracted from the total number of Hoechstâ€positive cells. Scale barâ€‰=â€‰100â€‰Î¼m. (C) Segmentation of an image taken from one well of a 96â€well plate. Inner subareas (I and II) were used for comparison between manual and automated analysis. (D) An amount of 20 inner subareas (indicated by colored dots) of a 96â€well plate cultured with Hoechstâ€stained HEpâ€2 cells were analyzed in 10Ã— magnification. The amount of manually (manual) counted HEpâ€2 cells was plotted versus the number of cells counted by digital image analysis software (software).

To verify the accuracy of automated detection, approximately 25,000 DAPIâ€stained cells were also manually counted. To ensure accuracy during manual counting, the image of the well was divided into subareas (FigureÂ 2C). Representative subareas were analyzed and counts are shown in FigureÂ 2D. Thereby, both counts (manually counted: 25,125 cells, detected by software: 25,693 cells) differ 2% from each other (FigureÂ 2) and can be considered as comparable methods. We fitted a linear model (estimated using OLS) to predict manual counting with software counting (formula: manual ~ software). The model explains a statistically significant and substantial proportion of variance (R 2â€‰=â€‰0.99, F(1, 17) =â€‰2042.69, pâ€‰<â€‰0.001, adj. R 2â€‰=â€‰0.99). The model's intercept, corresponding to softwareâ€‰=â€‰0, is at âˆ’91.45 (95% CI [âˆ’175.24, âˆ’7.66], t(17) = âˆ’2.30, pâ€‰=â€‰0.034). Within this model, the effect of software is statistically significant and positive (betaâ€‰=â€‰1.03, 95% CI [0.98, 1.08], t(17) =â€‰45.20, pâ€‰<â€‰0.001; Std. betaâ€‰=â€‰1.00, 95% CI [0.95, 1.04]). Standardized parameters were obtained by fitting the model on a standardized version of the dataset.

3.2 Automated image analysis reveals: LEDGF/p75 expression affects proliferation and chemoresistance in a range of cell lines

After accuracy verification of the software, we examined genetically LEDGFâ€modified U2OS, HEpâ€2, and LoVo cell lines regarding their proliferation capacity and chemosensitivity. Here, initially, we compared the SRB and PI/Hoechst staining assays with each other. In comparison to the automated image analysis software, SRB assays showed no significant difference in growth behavior (FigureÂ 3), if only three technical replicates are used.

FIGURE 3 LEDGF/p75 expression levels affect proliferation. Wildtype (WT), LEDGF knockout (KO), and LEDGF/p75 (OE) cells were seeded, cultivated for indicated time periods and then coâ€stained with Hoechst and PI (Aâ€“C, the amount of living cells was determined by subtracting PIâ€positive cells from Hoechstâ€positive cells.) or analyzed by the SRB assay (Dâ€“F). Proliferation of nonâ€treated (A) U2OS cells for 24â€‰h, (pWTâ€KOâ€‰=â€‰0.0632, pKOâ€OEâ€‰=â€‰0.0134, pOEâ€WTâ€‰=â€‰0.4341), 48â€‰h (pWTâ€KOâ€‰=â€‰0.2707, pKOâ€OEâ€‰=â€‰0.0397, pOEâ€WTâ€‰=â€‰0.3434), 72â€‰h (pWTâ€KOâ€‰=â€‰0.6396, pKOâ€OEâ€‰=â€‰0.0990, pOEâ€WTâ€‰=â€‰0.5716) and 96â€‰h (pWTâ€KOâ€‰=â€‰0.0400, pKOâ€OEâ€‰=â€‰0.0021, pOEâ€WTâ€‰=â€‰0.0022) (B) HEpâ€2 cells for 24â€‰h (pWTâ€KOâ€‰=â€‰0.0196, pKOâ€OEâ€‰=â€‰0.0014, pOEâ€WTâ€‰=â€‰0.0770), 48â€‰h (pWTâ€KOâ€‰=â€‰0.0687, pKOâ€OEâ€‰=â€‰0.0249, pOEâ€WTâ€‰=â€‰0.6958), 72â€‰h (pWTâ€KOâ€‰=â€‰0.0040, pKOâ€OEâ€‰=â€‰0.00007, pOEâ€WTâ€‰=â€‰0.0025) and 96â€‰h (pWTâ€KOâ€‰=â€‰0.0389, pKOâ€OEâ€‰=â€‰0.0007, pOEâ€WTâ€‰=â€‰0.0151) and (C) LoVo cells for 24â€‰h, 48â€‰h (pWTâ€KOâ€‰=â€‰0.0052, pKOâ€OEâ€‰=â€‰0.0076, pOEâ€WTâ€‰=â€‰0.9277), 72â€‰h (pWTâ€KOâ€‰=â€‰0.0008, pKOâ€OEâ€‰=â€‰0.0007, pOEâ€WTâ€‰=â€‰0.9901) and 96â€‰h (pWTâ€KOâ€‰=â€‰0.0005, pKOâ€OEâ€‰=â€‰0.0002, pOEâ€WTâ€‰=â€‰0.4588) analyzed by digital image analysis software. Proliferation of nonâ€treated (D) U2OS cells, (E). HEpâ€2 cells and (F). LoVo cells analyzed by the SRB assay. *â€‰=â€‰pâ€‰>â€‰0.05, **â€‰=â€‰pâ€‰>â€‰0.01, ***â€‰=â€‰pâ€‰>â€‰0.001.

In the VideoScan analysis, the investigated WT cell lines exhibited different proliferative capacities while U2OS showed only a threefold increase in cell number after 72â€‰h, LoVo and HEpâ€2 cells showed a fivefold and sevenfold increase, respectively (FigureÂ 3A). LEDGF KO significantly reduced the proliferation rate in faster proliferating LoVo and HEpâ€2 cells, while in U2OS cells only after longer cultivation (96â€‰h) the proliferation in LEDGF KO cells stagnated in comparison to the WT. As expected, the proliferation analysis showed that LEDGF/p75 overexpression cells are proliferating significantly faster than LEDGF KO cells, correlating with longer cultivation time independent of the cell type; however, this effect was less pronounced in slower dividing U2OS cells (FigureÂ 3). LEDGF OE in HEpâ€2 cells was strong also in comparison to the WT expression level (FigureÂ 6D) which was reflected by a significantly enhanced proliferation in comparison to the WT (FigureÂ 3B). In addition, the chemosensitivity towards etoposide regarding the LEDGF status was investigated (FigureÂ 4). As there was no difference in growth behavior between untreated cells and cells treated with DMSO, untreated cells were used as control for calculation. A low etoposide concentration (5â€‰Î¼M) already resulted in 40%â€“60% killing rate after 48â€‰h in all WT cells. Similar to the proliferative behavior, LEDGF KO caused a significant increase in the killing rate as compared to the WT cells; however in U2OS, cells this effect was diminished and only after 72â€‰h etoposide visible. This enhanced chemosensitivity was effectively reversed by overexpressing LEDGF/p75. Moreover, LEDGF OE resulted partially, even, in a significantly increased chemoresistance. As already shown in the proliferation study, the SRB assay was able to detect increasing killing rates in all cell lines (FigureÂ 4Dâ€“F), but no significant difference dependent on the LEDGF expression level.

FIGURE 4 LEDGF/p75 expression affects chemoresistance towards etoposide. Wildtype (WT), LEDGF knockout (KO), and LEDGF/p75 (OE) cells were seeded and after 24â€‰h, treated with 5â€‰Î¼M etoposide (ETP) for indicated the times and subsequently coâ€stained with Hoechst and PI (Aâ€“C, the amount of living cells was determined by subtracting PIâ€positive cells from Hoechstâ€positive cells) or analyzed by the SRB assay (Dâ€“F). After 24â€‰h growth, killing of (A) U2OS cell lines treated with 5â€‰Î¼M etoposide for 24â€‰h (pWTâ€KOâ€‰=â€‰0.0699, pKOâ€OEâ€‰=â€‰0.0688, pOEâ€WTâ€‰=â€‰0.9991), 48â€‰h (pWTâ€KOâ€‰=â€‰0.9880, pKOâ€OEâ€‰=â€‰0.0392, pOEâ€WTâ€‰=â€‰0.0469) and 72â€‰h (pWTâ€KOâ€‰=â€‰0.0194, pKOâ€OEâ€‰=â€‰0.0002, pOEâ€WTâ€‰=â€‰0.0035), (B) HEpâ€2 cell lines treated with 5â€‰Î¼M etoposide for 24â€‰h (pWTâ€KOâ€‰=â€‰0.8391, pKOâ€OEâ€‰=â€‰0.7181, pOEâ€WTâ€‰=â€‰0.9762), 48â€‰h (pWTâ€KOâ€‰=â€‰0.0091, pKOâ€OEâ€‰=â€‰0.0002, pOEâ€WTâ€‰=â€‰0.0072) and 72â€‰h (pWTâ€KOâ€‰=â€‰0.0430, pKOâ€OEâ€‰=â€‰0.0006, pOEâ€WTâ€‰=â€‰0.0099) and (C) LoVo cell lines treated with 5â€‰Î¼M etoposide for 24â€‰h (pWTâ€KOâ€‰=â€‰0.0025, pKOâ€OEâ€‰=â€‰0.0002, pOEâ€WTâ€‰=â€‰0.0306), 48â€‰h (pWTâ€KOâ€‰=â€‰0.0625, pKOâ€p75â€‰=â€‰0.0035, pOEâ€WTâ€‰=â€‰0.0841) and 72â€‰h (pWTâ€KOâ€‰=â€‰0.2205, pKOâ€OEâ€‰=â€‰0.0303, pOEâ€WTâ€‰=â€‰0.3204) were analyzed by digital image analysis software. Additionally, after 24â€‰h growth, killing of (D) U2OS cells, (E) HEpâ€2 cells and (F). LoVo cells treated with 5â€‰Î¼M etoposide for indicated time points were analyzed by the SRB assay. Survival rate was determined in comparison to the untreated control. *â€‰=â€‰pâ€‰>â€‰0.05, **â€‰=â€‰pâ€‰>â€‰0.01, ***â€‰=â€‰pâ€‰>â€‰0.001.

3.3 Knockout of LEDGF/p75 renders cells more chemosensitive towards etoposide

The median effective dose (ED50) was determined to draw conclusions about the efficacy of etoposide as a chemotherapeutic agent in LEDGF KO or LEDGF/p75 knockin mutations in various reference and colorectal cancer cell lines. While FACS analysis showed much higher overall ED50 values in HEpâ€2 cells and no difference between HEpâ€2 WT and HEpâ€2 LEDGF/p75 OE cells, automated image analysis software acted more sensitive and detected lower overall ED50 valued and a significant difference in resistance when comparing HEpâ€2 LEDGF/p75 OE cells with HEpâ€2 WT cells (FigureÂ 5A). The analysis of the LoVo cell lines showed that the ED50 values for all three cell lines are very close to each other and that significant but weak differences can be observed, whereas the analysis using automated image analysis shows a well separated and significantly different ED50 distribution between the WT, the LEDGF KO and the LEDGF/p75 overexpressing cell lines (FigureÂ 5B). Looking at the analysis of the ED50 values for the U2OS cells, it is noticeable that the FACS analysis does not show any significant differences between U2OS WT and U2OS LEDGF/p75. The automated image analysis software can clearly show this small but significant difference (FigureÂ 5C).

FIGURE 5 ED50 determination of different cell lines using FACS analysis and automated image analysis software. Determination of ED50 value was performed on wildtype (WT), LEDGF knockout (KO), and LEDGF/p75 (OE) cells, treated with indicated concentrations of etoposide for 48â€‰h etoposide, followed by 3â€‰days of recovery. Viable (A) HEpâ€2 cells, (B) LoVoâ€cells, and (C) U2OS cells were analyzed by the digital image analysis software (upper histograms) whereas a parallel run was analyzed by FACS (lower histogram). Doseâ€“response curves were fitted with multiparametric functions from the drc package. 29 , 31 The optimal model was selected by using the AIC as criterion. The triangles on the xâ€axis represent the dose of etoposide needed to reach ED50. *pâ€‰<â€‰0.05.

3.4 Generation of different CRISPR/Cas9â€modified LEDGF cancer cell models

The generation of CRISPR/Cas9â€modified LEDGF Hepâ€2 cell models has been described previously. 8 Additionally, LEDGFâ€modified U2OS and LoVo cell lines were generated. To achieve a complete LEDGF KO, a specific sgRNA targeting exon 1 of PSIP1 gene was designed (FigureÂ 6A). Thereby, the transient transfection with a nonâ€viral px458_DFS70_E1 vector allowed an enrichment of Cas9â€positive cells via FACS sorting using EGFP as a marker. Subsequently, LEDGF/p75 expression cassette was integrated at the human safe harbor locus AAVS1 (directed integration to avoid nonspecific side effects) using CRISPR/Cas9 (FigureÂ 6B). Cell lines were established from singleâ€cell clones and complete LEDGF KO was verified on protein level (FigureÂ 6C,D) and on genomic level (Supplement 4â€”DataÂ S1). The robust EGFPâ€tagged LEDGF/p75 expression and correct subcellular localization (in the nucleus) was determined by immunofluorescence (FigureÂ 6C) and immunoblotting (FigureÂ 6D), where LEDGF/p75 OE cells show an up to 10â€fold increased LEDGF/p75 expression, compared to the expression in WT cells (FigureÂ 6E). Note, the membrane was stripped between LEDGF/p75 and Î±â€actinin protein detection and to allow an appropriate identification of EGFPâ€LEDGF/p75 expression, an antiâ€rabbit secondary antibody was used, whereas an antiâ€mouse antibody was used for the detection of Î±â€actin expression. In LoVo cell lines, an antiâ€Î²â€tubulin antibody was used due to low detection level (FigureÂ 6D).

FIGURE 6 Generation of CRISPR/Cas9â€modified LEDGF cancer cell models. (A) Scheme of LEDGF knockout generation: Specific sgRNA for Exon 1 of LEDGFâ€coding gene (PSIP1) was designed to introduce a targetâ€specific DNA doubleâ€strand break (DNA DSB) with CRISPR/Cas9 technology. Due to endogenous errorâ€prone nonâ€homologous end joining (NHEJ) pathway, indel mutations can cause a frameshift leading to premature stop codons and subsequent gene knockout (LEDGF KO). (B) Scheme of LEDGF/p75 knockin generation: LEDGF overexpressing cells were created by introducing a DNA DSB at genomic safe harbor locus AAVS1 using an AAVS1â€specific sgRNA and an HDR template containing EGFPâ€LEDGF expression cassette (ELC) flanked by homologous arms (HA) to the cutting site at the AAVS1 locus. After the induction of a DSB, homologyâ€directed repair (HR) pathway mediates the integration of the ELC. (C) Indirect immunofluorescence of HEpâ€2, U2OS and LoVo cell lines: wildtype (WT), LEDGF KO (KO) and LEDGF/p75 overexpression (OE). Representative confocal images show nuclei (DAPI, blue) and Câ€LEDGF (red, Câ€terminal binding antibody) (scale barâ€‰=â€‰20â€‰Î¼m). (D) Immunoblot using antibodies against Câ€terminal LEDGF and Î±â€actinin or Î²â€tubulin as loading control. (E) Relative expression level of LEDGF/p75 in WT, LEDGF KO and LEDGF/p75 OE in HEpâ€2 (pWTâ€KOâ€‰=â€‰0.0022, pKOâ€p75â€‰=â€‰1â€‰Ã—â€‰10âˆ’7, pWTâ€p75â€‰=â€‰3â€‰Ã—â€‰10âˆ’7), U2OS (pWTâ€KOâ€‰=â€‰0.0003, pKOâ€p75â€‰=â€‰1â€‰Ã—â€‰10âˆ’7, pWTâ€p75â€‰=â€‰6â€‰Ã—â€‰10âˆ’7) and LoVo (pWTâ€KOâ€‰=â€‰0.0432, pKOâ€p75â€‰=â€‰1.7â€‰Ã—â€‰10âˆ’6, pWTâ€p75â€‰=â€‰3.8â€‰Ã—â€‰10âˆ’6) cell lines, compared to the corresponding loading control. **pâ€‰<â€‰0.01, ***pâ€‰<â€‰0.001.

3.5 LEDGF KO causes an increase in DNA damage

LEDGF is involved in DNA damage repair, and we have previously shown that upon LEDGF KO, the ğ›¾H2AX foci formation is markedly increased, even without chemotherapeutic treatment. 8 ğ›¾H2AX is the marker for DNA doubleâ€strand breaks (DSB), the most severe DNA lesion. Therefore, we determined the ğ›¾H2AX foci formation in the investigated cell models. The immunofluorescence analysis (FigureÂ 7Aâ€“C) revealed significant upregulated expression of ğ›¾H2AX in all LEDGF KO cells compared to the corresponding WT cells in HEpâ€2 (3â€fold, pWTâ€KOâ€‰=â€‰0.005), U2OS (2.6â€fold, pWTâ€KOâ€‰=â€‰0.002) and LoVo (10â€fold, pWTâ€KOâ€‰=â€‰8.5â€‰Ã—â€‰10âˆ’6) cells. This effect can be significantly reversed by LEDGF/p75 overexpression (FigureÂ 7Dâ€“F).

FIGURE 7 LEDGF/p75 reâ€expression reverses dysregulation of DNA damage response. Representative confocal images after indirect immunofluorescence with DAPI (blue) and antiâ€ğ›¾H2AX (red) of (A) HEpâ€2 WT, KO, and LEDGF/p75 OE cells (B) U2OS WT, KO, and LEDGF/p75 OE cells and (C) LoVo WT, KO, and LEDGF/p75 OE cells. Confocal images were then used for the analysis of ğ›¾H2AX foci per nucleus (at least 100 nuclei were counted) in (D) HEpâ€2 WT, KO, and LEDGF/p75 OE cells (pWTâ€KOâ€‰=â€‰0.005, pKOâ€p75â€‰=â€‰0.002, pWTâ€p75â€‰=â€‰0.997), (E) U2OS WT, KO, and LEDGF/p75 OE cells (pWTâ€KOâ€‰=â€‰0.002, pKOâ€p75â€‰=â€‰0.044, pWTâ€p75â€‰=â€‰0.163) and (F) LoVo WT, KO, and LEDGF/p75 OE cells (pWTâ€KOâ€‰=â€‰8.5â€‰Ã—â€‰10âˆ’6, pKOâ€p75â€‰=â€‰5.3â€‰Ã—â€‰10âˆ’6, pWTâ€p75â€‰=â€‰0.469) using the NucDetect software, nâ€‰=â€‰3 (Scale barâ€‰=â€‰20â€‰Î¼m): *pâ€‰<â€‰0.05, **pâ€‰<â€‰0.01, ***pâ€‰<â€‰0.001.

4 DISCUSSION

Proliferation analysis and cytotoxicity screenings are standard procedures in medical research. The demand on the tests is that they are reliable, fast, and easy to handle. Plenty of methods are available, but many of them have drawbacks. The routine use of colorimetric staining assays like NRU assay, 32 crystal violet assay, 33 , 34 and SRB assay 11 (Supplement 5â€”DataÂ S1) often leads to inconclusive results with high standard deviations, caused by excess binding of dyes, incomplete washing steps and a low sensitivity. In addition, these assays stain any proteins that are present. Alternatively, metabolic activity assays, such as the MTT/MTS, XTT, LDH, WST assays 35 , 36 , 37 , 38 , 39 or fluorometric assays like the almarBlue assay, 40 , 41 the CFDAâ€AM assay, 40 , 42 and the Annexin V assay 43 can be used (Supplement 5â€”DataÂ S1). These are also colorimetric assays, but detection depends on the conversion of added chemicals which correlates with the amount of mitochondria in a given cell and activity of cellular metabolism. Therefore, these assays cannot be used for comparison between different cell lines. Nevertheless, metabolic assays show an increased cytotoxicity, chemicals may interfere with possible tested drugs and again no quantitative statement can be made about the corresponding cell number. Another accurate possibility for analysis of cytotoxicity can be the analysis of exposed phosphatidylserine residues on the cellular membrane using the Annexinâ€V assay. During apoptosis, phosphatidylserine flips from the inner cell membrane to the outer cell membrane, and the amount corresponds to early or late apoptosis. Due to fluorescence labeling, these events can be tracked by a flow cytometer or fluorescence microscope, allowing the detailed analysis of each single cells 44 (Supplement 5â€”DataÂ S1). Nevertheless, all protocols contain many individual washing and staining steps which lead to multiplying errors. Moreover, many assays are not only timeâ€consuming but also cost intensive. To tackle this problem, we propose a fast and cheap protocol for a straightforward allâ€inâ€one staining and detection procedure (protocol in Supplement 1â€”DataÂ S1). Our assay requires no washing step, is independent of metabolic activity or amount of mitochondria, no additional fluorophore structures need to be added. There is no need to worry about interference with chemical substances, Hoechst/PI solution is directly added to living adherent cells with a high sensitivity of at least 500 cells/well of a 96â€well plate and subsequently stained nuclei are detected by automated microscopy and images are processed by software packages for viable cell quantification. In principle, and for users who do not possess the VideoScan system, our allâ€inâ€one attempt is compatible with all common fluorescence microscopes with and without automatic stage. After the detection procedure cells can even be used for further analysis like indirect immunofluorescence analysis. To verify the accuracy of our software, we performed a comparison between our program and manually counted cells, which resulted in a consistency of almost 98% of counted single cells (FigureÂ 2). Regarding the commercially available CCKâ€8 assay, which is one of the most used assays for cell proliferation and cytotoxicity, 45 , 46 , 47 our assay is 42 times less expensive (CCKâ€8 kit: 0.67 â‚¬/1 reaction, our assay: 0.016 â‚¬/1 reaction), more sensitiveâ€”we only need half of the cells to exceed the detection limit and not limited by metabolic activity of the cell. Our approach can make semiâ€quantitative statements, such as colorimetric assays, but can also accurately quantify the total number of cells and the number of dead cells simultaneously. Other protocols use fixed cells 48 for the analysis of DNA bound dyes while we use living cells where Hoechst stains all nuclei, but PI incorporates only in late apoptotic or necrotic cells whose cell membrane is permeable. This procedure can serve for a wide range of experiments like multiplex testing of different drugs to calculate ED50 level of different compounds, analyzing the increase/decrease in cytotoxicity after genomic modulation of cells (e.g., after knockâ€out or knock in of certain genes). It can be also used for checking proliferation of cells prior to experiments or comparing proliferation of different cell lines with potential new anticancer drugs.

In our study, the newly established assay was used to pursue the investigation of CRISPR/Cas9â€generated LEDGF KO and LEDGF/p75 overexpressing cell lines and their chemosensitivity. LEDGF/p75 has been reported to be overexpressed in different tumor and cancer cell lines 7 , 49 and to promote repair of DSBs by the homologous recombination repair pathway. 9 In our previous studies, we underlined the crucial role of LEDGF as a main player in initiating DNA repair processes. 8 The lack of LEDGF expression resulted in an accumulation of ğ›¾H2AX, 8 an early responder of the DNA repair and marker for DSBs. 50 In the present study, ğ›¾H2AX was significantly increased (depending on cell line between 2.6â€ and 10.5â€fold, FigureÂ 6) in LEDGF KO cells independent of the cell line, whereas LEDGF/p75 OE was able to rescue the WT phenotype with only background ğ›¾H2AX foci. Interestingly, ğ›¾H2AX is also an indicator for genome integrity and persistent ğ›¾H2AX foci formation is also related to tumorigenesis and genome instability. 51 , 52 This may suggest that LEDGF participates in the maintenance of genome integrity. Moreover, depletion of SETD2, the only methyltransferase catalyzes the triâ€methylation of histoneâ€h3 lysineâ€36 (H3K36me3), also causes persistent ğ›¾H2AX foci. 52 , 53 The histone reader LEDGF preferentially binds to H3K36me3 and its chromatin binding is reduced upon SETD2 depletion. 9 Additionally, our group found out, that persistent ğ›¾H2AX foci relate to insufficient degradation of ğ›¾H2AX due to interaction of LEDGF/p75 with the nuclear proteasome activator PA28ğ›¾. 8 The increased ğ›¾H2AX foci correlated with decreased proliferation rates in all LEDGF KO cells. This effect was reversed upon LEDGF overexpression and for strong LEDGF OE, the proliferation rate was even more elevated than in the WT cells. In breast cancer, upregulation of LEDGF/p75 expression also resulted in increased proliferation rates. 54

Additionally, chemosensitivity towards etoposide depending on the LEDGF status was investigated. As expected, LEDGF KO induced a sensitizing effect, which indicates that increased ğ›¾H2AX is related to genomic instability and the cells are less stress resistant. On the contrary, LEDGF/p75 OE not only reversed this sensitizing effect, but partially led to an even higher chemoresistance against etoposide. Previously, chemoresistance has been described to be correlated with increased LEDGF/p75 expression in prostate cancer. 6 Furthermore, the higher chemoresistance of LEDGF/p75 OE might also be related to the role of the shorter splice variant LEDGF/p52, which plays rather a proâ€apoptotic role and is considered as a counterpart of antiapoptotic LEDGF/p75. 55 In fact, WT cell lines most likely express both splice variants LEDGF/p75 and LEDGF/p52. However, we only verified the expression of the longer splice variant p75 (FigureÂ 5D). Nonetheless, LEDGF sgRNA targets exon 1 and thereby knocks out both splice variants. LEDGF/p75 OE model was established using LEDGF KO cells and therefore potential LEDGF/p52 expression was not reconstituted. Therefore, we cannot exclude that LEDGF/p52 might counteract LEDGF/p75 in WT cells leading to an altered proliferation and chemosensitivity. Nonetheless, specific depletion of LEDGF/p52 had no effect on chemosensitivity towards camptothecin. 9

5 CONCLUSION

In summary, our data revealed that LEDGF depletion causes increased DNA damage as indicated by elevated ğ›¾H2AX and resulting most likely in genome instability. Chemosensitivity towards etoposide depends on the expression level of LEDGF/p75, and higher LEDGF/p75 expression levels lead to chemoresistance. Moreover, we established a fast and cheap highâ€throughput assay for proliferation and cytotoxicity screenings. This fluorescenceâ€based approach uses Hoechst/PI staining on nonâ€fixed, living cells in combination with automated microscopy and analysis, leading to accurate cell count with live/dead discrimination. For the analysis, we used openâ€source software that can be used modularly in different scenarios. Moreover, all needed components are cheap, no cell fixation or washing is required.

AUTHOR CONTRIBUTIONS

Victoria Liedtke: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); project administration (equal); visualization (equal); writing â€“ original draft (equal). Romano Weiss: Data curation (equal); formal analysis (equal); investigation (equal); software (equal); writing â€“ review and editing (equal). Anastasia Skifov: Investigation (equal). Stefan RÃ¶diger: Conceptualization (equal); funding acquisition (equal); methodology (equal); resources (equal); supervision (equal); validation (equal); writing â€“ review and editing (equal). Lysann Schenk: Conceptualization (equal); funding acquisition (equal); methodology (equal); resources (equal); supervision (equal); validation (equal); writing â€“ review and editing (equal).

FUNDING INFORMATION

This work was supported by PRAEMED.BIOâ€”PrÃ¤zisionsmedizin durch biomarkerbasierte Diagnostik of the Federal Ministry of Education and Research (03WKDB2C, BMBF, Germany) and the Friedrichâ€Naumann Foundation for Freedom.

CONFLICT OF INTEREST STATEMENT

The authors have no conflicts of interest to declare.

ETHICS STATEMENT

Not Applicable.

CLINICAL TRIAL REGISTRATION NUMBER

Not Applicable.

Supporting information

Data S1:

ACKNOWLEDGEMENTS

We would like to thank Alexander BÃ¶hm and JÃ¶rg Nitschke for their support during the conduction of the experiments. Open Access funding enabled and organized by Projekt DEAL.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.
==== Refs
REFERENCES

1 Mitra S , Sarker J , Mojumder A , etÂ al. Genome editing and cancer: how far has research moved forward on CRISPR/Cas9? Biomed Pharmacother. 2022;150 :113011.35483191
2 Zhang H , Qin C , An C , etÂ al. Application of the CRISPR/Cas9â€based gene editing technique in basic research, diagnosis, and therapy of cancer. Mol Cancer. 2021;20 (1 ):126.34598686
3 McCarty NS , Graham AE , StudenÃ¡ L , Ledesmaâ€Amaro R . Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nat Commun. 2020;11 (1 ):1281.32152313
4 Ocegueraâ€Yanez F , Kim SI , Matsumoto T , etÂ al. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods. 2016;101 :43â€55.26707206
5 Basu A , Woodsâ€Burnham L , Ortiz G , etÂ al. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol. 2015;161 (2 ):241â€250.26235378
6 RÃ­osâ€ColÃ³n L , Cajigasâ€Du Ross CK , Basu A , etÂ al. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget. 2017;8 (15 ):24915â€24931.28212536
7 Ochs RL , Mahler M , Basu A , etÂ al. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med. 2016;16 :273â€293.26088181
8 Liedtke V , SchrÃ¶der C , Roggenbuck D , etÂ al. LEDGF/p75 is required for an efficient DNA damage response. Int J Mol Sci. 2021;22 (11 ):5866.34070855
9 Daugaard M , Baude A , Fugger K , etÂ al. LEDGF (p75) promotes DNAâ€end resection and homologous recombination. Nat Struct Mol Biol. 2012;19 (8 ):803â€810.22773103
10 Skehan P , Storeng R , Scudiero D , etÂ al. New colorimetric cytotoxicity assay for anticancerâ€drug screening. JNCI J Natl Cancer Inst. 1990;82 (13 ):1107â€1112.2359136
11 Vichai V , Kirtikara K . Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1 (3 ):1112â€1116.17406391
12 Schneider J , Weiss R , Ruhe M , etÂ al. Open source bioimage informatics tools for the analysis of DNA damage and associated biomarkers. J Lab Precis Med. 2019;4 :21.
13 RÃ¶diger S , Schierack P , BÃ¶hm A , etÂ al. A highly versatile microscope imaging technology platform for the multiplex realâ€time detection of biomolecules and autoimmune antibodies. In: Seitz H , Schumacher S , eds. Molecular Diagnostics [Internet]. Springer Berlin Heidelberg; 2012. p. 35â€“74. (Advances in Biochemical Engineering/Biotechnology; vol. 133). Accessed June 3, 2020. http://link.springer.com/10.1007/10_2011_132
14 Willitzki A , Lorenz S , Hiemann R , etÂ al. Fully automated analysis of chemically induced Î³H2AX foci in human peripheral blood mononuclear cells by indirect immunofluorescence: fully automated Î³H2AX foci analysis in PBMCs. Cytometry A. 2013;83 (11 ):1017â€1026.24009179
15 Reddig A , RÃ¼be CE , RÃ¶diger S , Schierack P , Reinhold D , Roggenbuck D . DNA damage assessment and potential applications in laboratory diagnostics and precision medicine. J Lab Precis Med. 2018;3 :31.
16 Jurischka C , Dinter F , Sowa M , etÂ al. Tyramide signal amplification as universal detection method on protein coated microbeads. J Cell Biotechnol. 2019;4 (1â€“2 ):15â€22.
17 Dinter F , Burdukiewicz M , Schierack P , etÂ al. Simultaneous detection and quantification of DNA and protein biomarkers in spectrum of cardiovascular diseases in a microfluidic microbead chip. Anal Bioanal Chem. 2019;411 (29 ):7725â€7735.31760445
18 FrÃ¶mmel U , Lehmann W , RÃ¶diger S , etÂ al. Adhesion of human and animal Escherichia coli strains in association with their virulenceâ€associated genes and phylogenetic origins. Appl Environ Microbiol. 2013;79 (19 ):5814â€5829.23872574
19 Schiebel J , BÃ¶hm A , Nitschke J , etÂ al. Genotypic and phenotypic characteristics associated with biofilm formation by human clinical Escherichia coli isolates of different pathotypes. Schaffner DW, editor. Appl Environ Microbiol. 2017;83 (24 ):e01660â€17.28986371
20 Ran FA , Hsu PD , Wright J , Agarwala V , Scott DA , Zhang F . Genome engineering using the CRISPRâ€Cas9 system. Nat Protoc. 2013;8 (11 ):2281â€2308.24157548
21 Ocegueraâ€Yanez F . Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. 2016;13 .
22 Image J . Accessed August 23, 2023. https://imagej.nih.gov/ij/
23 Ni D , Xu P , Gallagher S . Immunoblotting and immunodetection. Curr Protoc Cell Biol. 2017;74 (1 ):6.2.1â€6.2.37. doi:10.1002/cpcb.18
24 R: The R Project for Statistical Computing Accessed December 16, 2022. https://www.râ€project.org/
25 Smith RA . The effect of unequal group size on Tukey's HSD procedure. Psychometrika. 1971;36 (1 ):31â€34.
26 RÃ¶diger S , Friedrichsmeier T , Kapat P , Michalke M . RKWard: a comprehensive graphical user interface and integrated development environment for statistical analysis with R. J Stat Softw. 2012;49 (9 ):1â€34.
27 Breheny P , Burchett W . Visualization of regression models using visreg. R I Dent J. 2017;9 (2 ):56â€71.
28 Chilimoniuk J , Gosiewska A , SÅ‚owik J , etÂ al. countfitteR: efficient selection of count distributions to assess DNA damage. Ann Transl Med. 2021;9 (7 ):528.33987226
29 Ritz C , Baty F , Streibig JC , Gerhard D . Doseâ€response analysis using R. PLoS One. 2015;10 (12 ):e0146021.26717316
30 SilMon . SilMon/Cellâ€Morphologyâ€Notebook: 1.2. Zenodo. 2023; Accessed January 27, 2023. https://zenodo.org/record/7568240
31 Ritz C , Streibig JC . Bioassay analysis using R. J Stat Softw. 2005;12 (5 ):1â€22: Available from: http://www.jstatsoft.org/v12/i05/
32 Repetto G , Del Peso A , Zurita JL . Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008;3 (7 ):1125â€1131.18600217
33 Edwards V , Markovic E , Matisons J , Young F . Development of an inÂ vitro reproductive screening assay for novel pharmaceutical compounds. Biotechnol Appl Biochem. 2008;51 (2 ):63â€71.18171324
34 Nilles J , Weiss J , Theile D . Crystal violet staining is a reliable alternative to bicinchoninic acid assayâ€based normalization. Biotechniques. 2022;73 (3 ):131â€135.36000337
35 Papadimitriou M , Hatzidaki E , Papasotiriou I . Linearity comparison of three colorimetric cytotoxicity assays. J Cancer Ther. 2019;10 (7 ):580â€590.
36 Delrue I , Pan Q , Baczmanska AK , Callens BW , Verdoodt LLM . Determination of the selection capacity of antibiotics for gene selection. Biotechnol J. 2018;13 (8 ):1700747.
37 Plumb JA . Cell sensitivity assays: the MTT assay. Cancer Cell Culture. Humana Press; 2003:165â€170 Accessed August 25, 2023. http://link.springer.com/10.1385/1â€59259â€406â€9:165
38 Bauhammer I , Sacha M , Haltner E . Validation and stability analysis of a modified lactate dehydrogenase (LDH) test method to be employed for an inÂ vitro viable skin model. Heliyon. 2019;5 (5 ):e01618.31111108
39 Smith SM , Wunder MB , Norris DA , Shellman YG . A simple protocol for using a LDHâ€based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One. 2011;6 (11 ):e26908.22125603
40 Hamid R , Rotshteyn Y , Rabadi L , Parikh R , Bullock P . Comparison of alamar blue and MTT assays for high throughâ€put screening. Toxicol InÂ Vitro. 2004;18 (5 ):703â€710.15251189
41 O'Brien J , Wilson I , Orton T , Pognan F . Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity: resazurin as a cytotoxicity assay. Eur J Biochem. 2000;267 (17 ):5421â€5426.10951200
42 Ganassin RC , Bols NC . Growth of rainbow trout hemopoietic cells in methylcellulose and methods of monitoring their proliferative response in this matrix. Methods Cell Sci. 2000;22 (2/3 ):147â€152.11264947
43 Miller E . Apoptosis measurement by annexin V staining. Cancer Cell Culture. Humana Press; 2003:191â€202 Available from: http://link.springer.com/10.1385/1â€59259â€406â€9:191
44 Banfalvi G . Methods to detect apoptotic cell death. Apoptosis. 2017;22 (2 ):306â€323.28035493
45 Liao J , Zheng H , Fei Z , etÂ al. Tumorâ€targeting and pHâ€responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin. Int J Biol Macromol. 2018;113 :737â€747.29505869
46 Liu Z , Li G , Long C , Xu J , Cen J , Yang X . The antioxidant activity and genotoxicity of isogarcinol. Food Chem. 2018;253 :5â€12.29502843
47 Wang X , Zhang H , Bai M , etÂ al. Exosomes serve as nanoparticles to deliver antiâ€miRâ€214 to reverse chemoresistance to cisplatin in gastric cancer. Mol Ther. 2018;26 (3 ):774â€783.29456019
48 LigasovÃ¡ A , Koberna K . Quantification of fixed adherent cells using a strong enhancer of the fluorescence of DNA dyes. Sci Rep. 2019;9 (1 ):8701.31213648
49 Basu A , Rojas H , Banerjee H , etÂ al. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types. PLoS One. 2012;7 (1 ):e30132.22276150
50 Ruhe M , Rabe D , Jurischka C , etÂ al. Molecular biomarkers of DNA damage in diffuse largeâ€cell lymphomaâ€”a review. J Lab Precis Med. 2019;4 :5.
51 Bonner WM , Redon CE , Dickey JS , etÂ al. Î³H2AX and cancer. Nat Rev Cancer. 2008;8 (12 ):957â€967.19005492
52 Georgoulis A , Vorgias C , Chrousos G , Rogakou E . Genome instability and Î³H2AX. Int J Mol Sci. 2017;18 (9 ):1979.28914798
53 Li L , Wang Y . Crossâ€talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA doubleâ€strand break repair. J Biol Chem. 2017;292 (28 ):11951â€11959.28546430
54 Singh DK , Gholamalamdari O , Jadaliha M , etÂ al. PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes. Carcinogenesis. 2017;38 (10 ):966â€975.28633434
55 Brownâ€Bryan TA , Leoh LS , Ganapathy V , etÂ al. Alternative splicing and caspaseâ€mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75. Mol Cancer Res. 2008;6 (8 ):1293â€1307.18708362
